PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2296
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK ; volume:6 ; number:1 ; day:09 ; month:6 ; year:2005 ; pages:1-6 ; date:12.2005
BMC family practice ; 6, Heft 1 (09.6.2005), 1-6, 12.2005
- Creator
-
Brett, Jo
- Contributor
-
Watson, Eila
Hewitson, Paul
Bukach, Colleen
Edwards, Adrian
Elwyn, Glyn
Austoker, Joan
SpringerLink (Online service)
- DOI
-
10.1186/1471-2296-6-24
- URN
-
urn:nbn:de:1111-201602186160
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Brett, Jo
- Watson, Eila
- Hewitson, Paul
- Bukach, Colleen
- Edwards, Adrian
- Elwyn, Glyn
- Austoker, Joan
- SpringerLink (Online service)
Other Objects (12)
Genetically adjusted PSA levels for prostate cancer screening
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
Qualitative insights into general practitioners views on polypharmacy
Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
Female Hyperplastic PSA-Positive Prostate Tissue in the Bladder Neck
Characterisation of the main PSA glycoforms in aggressive prostate cancer
PSA, PCA3 and the phi losophy of prostate cancer management
General practitioners’ views on use of patient reported outcome measures in primary care: a cross-sectional survey and qualitative study
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study
PSA
PSA
Die prognostische Aussagekraft des freien prozentualen PSA (f-PSA, t-PSA)
Genetically adjusted PSA levels for prostate cancer screening
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
Qualitative insights into general practitioners views on polypharmacy
Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
Female Hyperplastic PSA-Positive Prostate Tissue in the Bladder Neck
Characterisation of the main PSA glycoforms in aggressive prostate cancer
PSA, PCA3 and the phi losophy of prostate cancer management
General practitioners’ views on use of patient reported outcome measures in primary care: a cross-sectional survey and qualitative study
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study
PSA
PSA
Die prognostische Aussagekraft des freien prozentualen PSA (f-PSA, t-PSA)
Genetically adjusted PSA levels for prostate cancer screening
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
Qualitative insights into general practitioners views on polypharmacy
Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
Female Hyperplastic PSA-Positive Prostate Tissue in the Bladder Neck
Characterisation of the main PSA glycoforms in aggressive prostate cancer
PSA, PCA3 and the phi losophy of prostate cancer management
General practitioners’ views on use of patient reported outcome measures in primary care: a cross-sectional survey and qualitative study
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study
PSA
PSA